Company profile for AdipoPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AdipoPharma SAS is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company was created to commercialize the work of its founder, Dr. Vincent Marion PhD, MSc, and Biochemist and researcher at INSERM, the French National Institute for Health and Medical Research. Dr Marion’s team has...
AdipoPharma SAS is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company was created to commercialize the work of its founder, Dr. Vincent Marion PhD, MSc, and Biochemist and researcher at INSERM, the French National Institute for Health and Medical Research. Dr Marion’s team has spent more than a decade identifying therapeutic targets based on the adipocyte’s specific role in the metabolic effects of insulin resistance and diabetes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
Parc d’Innovation 650 Boulevard Gonthier d’Andernach 67400 Illkirch-Graf...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/30/3107799/0/en/AdipoPharma-Recognized-at-American-Diabetes-Association-85th-Annual-Meeting-for-PATAS-Its-First-in-Class-Whole-Body-Insulin-Sensitizing-Compound.html

GLOBENEWSWIRE
30 Jun 2025

https://www.globenewswire.com/news-release/2024/11/11/2978500/0/en/French-Biotech-Company-AdipoPharma-Secures-Funding-to-Initiate-Clinical-Trials-for-its-first-in-class-compound-for-Insulin-Resistance.html

GLOBENEWSWIRE
11 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty